KCNT1 Gain of Function in 2 Epilepsy Phenotypes is Reversed by Quinidine
Carol J Milligan, Melody Li, Elena V Gazina, Sarah E Heron, Umesh Nair, Chantel Trager, Christopher A Reid, Anu Venkat, Donald P Younkin, Dennis J Dlugos, Slave Petrovski, David B Goldstein, Leanne M Dibbens, Ingrid E Scheffer, Samuel F Berkovic, Steven Petrou
Annals of Neurology | WILEY | Published : 2014
Related Projects (5)
Awarded by National Health and Medical Research Council of Australia
Awarded by NIH National Institute of Neurological Disorders and Stroke [NINDS]
Awarded by NINDS
This work was supported by the Victorian Government through the Operational Infrastructure Scheme. This work was supported by the following grants from the National Health and Medical Research Council of Australia: Program Grant 628952 to S. F. B., I. E. S., S. Petrou, and L. M. D.; Training Fellowship 1016715 to S. E. H.; Senior Research Fellowship 1005050 to S. Petrou; Australia Fellowship 466671 to S. F. B.; Practitioner Fellowship 1006110 to I. E. S.; and Career Development Fellowship 1032603 to L. M. D.We thank the families for their participation in this study; Dr D. Lowenstein and colleagues from the Epilepsy Phenome/Genome Project (epgp.org; supported by grant NS053998 from the NIH National Institute of Neurological Disorders and Stroke [NINDS]) and Epi4K (epi4K.org; supported by grants NS053998, NS077274, NS077303, and NS077276 from NINDS) for their collaborative efforts that led to the identification of the individual with the P924L mutation included in this study.